HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnostic accuracy of glypican-3 in differentiating hepatocellular carcinoma from metastatic liver tumours.

AbstractOBJECTIVE:
To determine the diagnostic accuracy of Glypican-3 in differentiating hepatocellular carcinoma from metastatic liver tumours while taking histopathology as the gold standard..
METHODS:
The cross-sectional study was conducted at Shaukat Khanum Memorial Cancer Hospital, Lahore, Pakistan, from January 1 to June 30, 2016, and comprised cases of malignant liver tumours. Samples were collected from the pathology department. Glypican-3was applied on them. Tumours were classified as positive when they showed >5% positivity and negative when showing <5% positivity. Frequencies and percentages of cases showing GPC3 positivity and negativity along with frequency and percentages of hepatocellular carcinoma and metastatic tumours were calculated.
RESULTS:
Of the 240 patients, 143(59.58%) were males and 97 (40.42%) were females. Overall mean age was 54.65 ± 13.46 years. On histopathology, 134 cases were hepatocellular carcinoma (55.83%) and 106 (44. 17%) cases turned out to be metastatic carcinoma. Glypican-3staining was positive in 116 (48.33%) cases and negative in 124(51.67%). Sensitivity was 82%, Specificity 94.33%, positive predictive value 94.82% and negative predictive value 80.64%. Diagnostic accuracy was 87.5%.
CONCLUSIONS:
Glypican-3 was found to be a highly sensitive and specific Immunohistochemistry stain distinguishing hepatocellular carcinoma from the clear majority of metastatic carcinomas of the liver.
AuthorsSadia Majeed, Sajid Mushtaq, Muhammad Azam, Noreen Akhtar, Mudassar Hussain, Asif Loya
JournalJPMA. The Journal of the Pakistan Medical Association (J Pak Med Assoc) Vol. 68 Issue 7 Pg. 1029-1031 (Jul 2018) ISSN: 0030-9982 [Print] Pakistan
PMID30317296 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • GPC3 protein, human
  • Glypicans
Topics
  • Adolescent
  • Adult
  • Aged
  • Biomarkers, Tumor (metabolism)
  • Biopsy, Fine-Needle
  • Carcinoma, Hepatocellular (diagnosis, metabolism)
  • Cross-Sectional Studies
  • Diagnosis, Differential
  • Female
  • Glypicans (metabolism)
  • Humans
  • Liver (metabolism, pathology)
  • Liver Neoplasms (diagnosis, metabolism)
  • Male
  • Middle Aged
  • Neoplasm Metastasis (diagnosis)
  • Reproducibility of Results
  • Retrospective Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: